Return On Equity of CRESCENT BIOPHARMA, INC. from 30 Sep 2014 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
CRESCENT BIOPHARMA, INC. quarterly and annual Return On Equity in % history and change rate from 30 Sep 2014 to 30 Sep 2025.
  • CRESCENT BIOPHARMA, INC. Return On Equity for the quarter ending 30 Sep 2025 was -145%, a 213% decline year-over-year.
  • CRESCENT BIOPHARMA, INC. annual Return On Equity for 2024 was -471%, a 544% decline from 2023.
  • CRESCENT BIOPHARMA, INC. annual Return On Equity for 2023 was -73%, a 16% increase from 2022.
  • CRESCENT BIOPHARMA, INC. annual Return On Equity for 2022 was -87%, a 42% decline from 2021.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Change (%)
Return On Equity, Annual (%)
Return On Equity, YoY Annual Change (%)

CRESCENT BIOPHARMA, INC. Quarterly Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
Q3 2025 -145% -98% -213% 01 Jul 2025 30 Sep 2025
Q2 2025 -234% -117% -100% 01 Apr 2025 30 Jun 2025
Q1 2025 629% +718% 01 Jan 2025 31 Mar 2025
Q4 2024 -471% -398% -544% 01 Oct 2024 31 Dec 2024
Q3 2024 -46% +28% +37% 20 Sep 2024 30 Sep 2024
Q2 2024 -117% -45% -63% 01 Apr 2024 30 Jun 2024
Q1 2024 -88% -7% -8.9% 01 Jan 2024 31 Mar 2024
Q4 2023 -73% +14% +16% 01 Oct 2023 31 Dec 2023
Q3 2023 -74% +11% +13% 01 Jul 2023 30 Sep 2023
Q2 2023 -72% +11% +13% 01 Apr 2023 30 Jun 2023
Q1 2023 -81% -10% -14% 01 Jan 2023 31 Mar 2023
Q4 2022 -87% -26% -42% 01 Oct 2022 31 Dec 2022
Q3 2022 -85% -32% -60% 01 Jul 2022 30 Sep 2022
Q2 2022 -83% -37% -80% 01 Apr 2022 30 Jun 2022
Q1 2022 -71% -28% -66% 01 Jan 2022 31 Mar 2022
Q4 2021 -61% -25% -68% 01 Oct 2021 31 Dec 2021
Q3 2021 -53% -19% -56% 01 Jul 2021 30 Sep 2021
Q2 2021 -46% -14% -42% 01 Apr 2021 30 Jun 2021
Q1 2021 -43% -11% -35% 01 Jan 2021 31 Mar 2021
Q4 2020 -36% -3% -8.9% 01 Oct 2020 31 Dec 2020
Q3 2020 -34% -4% -12% 01 Jul 2020 30 Sep 2020
Q2 2020 -32% -4% -16% 01 Apr 2020 30 Jun 2020
Q1 2020 -32% -8% -32% 01 Jan 2020 31 Mar 2020
Q4 2019 -33% -12% -54% 01 Oct 2019 31 Dec 2019
Q3 2019 -31% -9% -41% 01 Jul 2019 30 Sep 2019
Q2 2019 -28% -5% -21% 01 Apr 2019 30 Jun 2019
Q1 2019 -24% +1% +5% 01 Jan 2019 31 Mar 2019
Q4 2018 -22% +14% +39% 01 Oct 2018 31 Dec 2018
Q3 2018 -22% +23% +51% 01 Jul 2018 30 Sep 2018
Q2 2018 -23% +34% +60% 01 Apr 2018 30 Jun 2018
Q1 2018 -25% +56% +69% 01 Jan 2018 31 Mar 2018
Q4 2017 -35% +44% +55% 01 Oct 2017 31 Dec 2017
Q3 2017 -44% +34% +43% 01 Jul 2017 30 Sep 2017
Q2 2017 -58% +16% +22% 01 Apr 2017 30 Jun 2017
Q1 2017 -82% -52% -176% 01 Jan 2017 31 Mar 2017
Q4 2016 -79% -52% -193% 01 Oct 2016 31 Dec 2016
Q3 2016 -78% -55% -244% 01 Jul 2016 30 Sep 2016
Q2 2016 -73% -53% -255% 01 Apr 2016 30 Jun 2016
Q1 2016 -30% -5% -22% 01 Jan 2016 31 Mar 2016
Q4 2015 -27% -8% -39% 01 Oct 2015 31 Dec 2015
Q3 2015 -23% -6% -34% 01 Jul 2015 30 Sep 2015
Q2 2015 -21% 01 Apr 2015 30 Jun 2015
Q1 2015 -24% 01 Jan 2015 31 Mar 2015
Q4 2014 -20% 01 Oct 2014 31 Dec 2014
Q3 2014 -17% 01 Jul 2014 30 Sep 2014

CRESCENT BIOPHARMA, INC. Annual Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
2024 -471% -398% -544% 01 Jan 2024 31 Dec 2024
2023 -73% +14% +16% 01 Jan 2023 31 Dec 2023
2022 -87% -26% -42% 01 Jan 2022 31 Dec 2022
2021 -61% -25% -68% 01 Jan 2021 31 Dec 2021
2020 -36% -3% -8.9% 01 Jan 2020 31 Dec 2020
2019 -33% -12% -54% 01 Jan 2019 31 Dec 2019
2018 -22% +14% +39% 01 Jan 2018 31 Dec 2018
2017 -35% +44% +55% 01 Jan 2017 31 Dec 2017
2016 -79% -52% -193% 01 Jan 2016 31 Dec 2016
2015 -27% -8% -39% 01 Jan 2015 31 Dec 2015
2014 -20% 01 Jan 2014 31 Dec 2014
* An asterisk sign (*) next to the value indicates that the value is likely invalid.